美国参与Amgen临床试验的参与者的多样性和代表性
E Racquel Racadio1, Angshu Rai2, Pinar Kizilirmak2
1Amgen Inc, Thousand Oaks, CA, USA. rracadio@amgen.com.
Journal of racial and ethnic health disparities
|September 27, 2023
概括
美国的临床试验多样性表明种族和少数民族的代表性不足. 来自Amgen试验 (2005-2020年) 的数据突出了差异,为更公平的健康研究提供了战略信息.
科学领域:
- 临床研究是临床研究.
- 卫生公平性健康公平性
- 人口统计分析 人口统计分析
背景情况:
- 在临床试验中实现多元化代表是研究界的一个关键目标.
- 了解试验参与者的人口资料对于评估公平性至关重要.
研究的目的:
- 描述美国参与者在Amgen临床试验中的人口特征,长达10年的时间.
- 为了识别跨治疗领域,指示和地理位置的代表性的变化.
主要方法:
- 采用了横截面的回顾性研究设计.
- 数据包括2005年至2020年期间参加Amgen 1-3期试验的参与者.
- 分析的重点是2012年1月1日至2021年6月30日期间完成的试验.
主要成果:
- 在258项试验中的31,619名参与者中,少数民族占五分之一 (亚洲人3%,黑人17%).
- 西班牙裔或拉丁裔参与者 (少数民族) 占研究人口的16%.
- 代表性因美国各州而异,大多数治疗领域主要包括白人参与者 (72-81%).
- 从2016年到2020年,男性代表比例不成比例地增加,大多数参与者年龄在18-65岁之间.
结论:
- 尽管努力实现多样性,但某些人群在临床试验中的代表性仍然不足.
- 这项研究提供了美国参与者在Amgen试验中的多样性的基线评估.
- 研究结果支持制定战略,以加强公平和代表性的临床研究.
关键词:
临床试验 临床试验临床试验中的多样性健康 公平 卫生 公平少数群体健康 少数群体健康少数民族的人口.参与者的多样性 参与者的多样性患者多样性 患者多样性患者代表团 患者代表团主题多样性 主题多样性更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.7K
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
16.8K
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Diversity in Cell Signaling Responses
6.5K
The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity.
Graded and Abrupt Responses
Some signaling systems generate...
Graded and Abrupt Responses
Some signaling systems generate...
6.5K
Bioequivalence: Overview
1.1K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.1K
Diversity of Antigen Receptors
620
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
620
Preclinical Development: Overview
4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
